Profile data is unavailable for this security.
About the company
OK Biotech Corporation is principally engaged in the manufacture and distribution of medical supplies and products. The Company primarily provides household medical glucose meters and disposable glucose testing strips. Its products are applied in the testing and monitoring of glucose value for diabetes patients, hospitals, clinic doctors and nurses, among others. The Company distributes its products principally in Taiwan, other Asian markets and the United States.
- Revenue in TWD (TTM)1.19bn
- Net income in TWD2.95m
- Incorporated2004
- Employees62.00
- LocationOK Biotech Co LtdNo.91, Section 2, Gongdao 5th RoadHSINCHU 300TaiwanTWN
- Phone+886 35160258
- Fax+886 35160028
- Websitehttps://www.okbiotech.com/
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apex Biotechnology Corp. | 1.68bn | 115.78m | 3.38bn | 641.00 | 29.30 | 1.88 | 17.65 | 2.02 | 1.15 | 1.15 | 16.71 | 17.97 | 0.6969 | 1.54 | 4.38 | -- | 4.81 | 5.41 | 6.00 | 7.24 | 31.68 | 26.54 | 6.90 | 6.89 | 1.98 | -- | 0.0787 | 84.56 | -25.29 | -3.88 | -36.31 | 4.01 | -21.20 | 5.35 |
| Chunghwa Chemical Synthsis&Biotech CoLtd | 2.09bn | 264.91m | 3.63bn | 243.00 | 13.71 | 1.08 | 7.97 | 1.74 | 3.41 | 3.41 | 26.83 | 43.20 | 0.4286 | 1.31 | 7.59 | -- | 5.44 | 9.03 | 6.39 | 10.56 | 36.30 | 43.26 | 12.70 | 20.15 | 0.6937 | -- | 0.265 | 24.83 | -1.45 | 15.40 | -43.14 | 2.49 | 36.95 | -7.79 |
| OK Biotech Co Ltd | 1.19bn | 2.95m | 3.82bn | 62.00 | 533.88 | 1.58 | 51.68 | 3.21 | 0.0487 | 0.0487 | 8.72 | 16.45 | 0.389 | 2.44 | 2.92 | -- | -0.052 | 3.06 | -0.0675 | 4.08 | 16.52 | 20.27 | -0.1337 | 6.01 | 1.60 | -2.97 | 0.1217 | 118.40 | -19.65 | 1.25 | -97.95 | -55.09 | 72.81 | -31.15 |
| Phytohealth Corp | 162.12m | -67.65m | 3.97bn | 84.00 | -- | 2.01 | -- | 24.50 | -0.3406 | -0.3406 | 0.8162 | 9.96 | 0.0687 | 0.628 | 5.49 | -- | -4.20 | -5.66 | -5.04 | -7.31 | 39.43 | 47.70 | -61.09 | -92.91 | 30.49 | -- | 0.0115 | -- | 19.95 | 8.62 | 40.67 | -- | -39.46 | -- |
| Bionime Corp | 1.81bn | 6.82m | 4.20bn | 671.00 | 659.52 | 2.21 | 24.29 | 2.32 | 0.1045 | 0.1045 | 29.42 | 31.22 | 0.3527 | 1.99 | 4.09 | -- | 0.1296 | 1.53 | 0.196 | 2.18 | 41.17 | 43.49 | 0.3675 | 3.71 | 0.563 | -0.2416 | 0.5923 | 173.70 | -20.58 | -2.64 | -93.18 | -45.41 | 21.20 | 0.0188 |
| Energenesis Biomedical Co Ltd | 7.02m | -246.83m | 4.22bn | -- | -- | 5.47 | -- | 601.52 | -3.37 | -3.37 | 0.0945 | 10.14 | 0.0102 | 2.76 | 6.82 | -- | -35.93 | -25.02 | -37.19 | -25.78 | 72.61 | 69.19 | -3,517.14 | -2,619.68 | 25.08 | -- | 0.0126 | -- | -2.63 | 9.01 | 1.99 | -- | -20.91 | -- |
Data as of May 17 2024. Currency figures normalised to OK Biotech Co Ltd's reporting currency: Taiwan Dollar TWD
0.54%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Dimensional Fund Advisors LPas of 09 May 2024 | 609.07k | 0.42% |
| SSgA Funds Management, Inc.as of 09 May 2024 | 147.00k | 0.10% |
| Dimensional Fund Advisors Ltd.as of 29 Feb 2024 | 27.14k | 0.02% |
| American Century Investment Management, Inc.as of 09 May 2024 | 1.00k | 0.00% |
| DFA Australia Ltd.as of 31 Dec 2023 | 900.00 | 0.00% |
More ▼
Data from 31 Mar 2024 - 16 May 2024Source: FactSet Research Systems Inc.
